How One Hematologist’s Curiosity Is Changing Care: Dr. Lauren Merz Redefines “Benign Ethnic Neutropenia”
Sindy Escobar Alvarez, Program Director for Medical Research at Doris Duke Foundation, posted on LinkedIn:
”Scientists take nagging questions, and through relentless pursuit of the answers, make discoveries that can change lives, including their own.
This trajectory is illustrated in a recent Medscape feature on hematologist Dr. Lauren Merz, whose curiosity about a condition flagged as “benign ethnic neutropenia” changed the course of her career. Despite the fact that this particular marker of a low neutrophil count has little clinical impact, it has kept patients out of clinical trials, made them ineligible for certain chemotherapies, and subjected others to needless invasive testing.
Dr. Merz, assistant professor at Rogel Cancer Center at the University of Michigan has led the DDF-supported work of the American Society of Hematology to develop new reference ranges for patients with the phenotype that causes this low neutrophil count, and test them nationwide.
Read the interview to see how her quick path from curiosity to action is changing medical understanding, and will improve patient care for millions.”
Stay updated with Hemostasis Today.
-
Dec 7, 2025, 16:06Pablo Corral on Why Early LDL-C Reduction Saves Lives
-
Dec 7, 2025, 15:53Paul Batty Congratulates Giulia Simini on Taking The Joint BSH-ASH Abstract Award
-
Dec 7, 2025, 15:35Federica Fogacci Presents The New ILEP Consensus Paper
-
Dec 7, 2025, 15:20Deep Molecular Modeling for Type 2A VWD from Omid Seidizadeh
-
Dec 6, 2025, 18:02ASH25 Day 1: Don’t Miss The Highlights
-
Dec 6, 2025, 15:44Atul Gupta on Where The Healthcare Innovation is Headed
-
Dec 6, 2025, 15:22Nathan White on How Inflammation Contributes to Coagulopathy After Trauma
-
Dec 6, 2025, 15:02Anas Younes on AstraZeneca’s Aims in Blood Cancer to Be Presented at ASH25
-
Dec 6, 2025, 14:08David Alderman: ASH25 is Live